OraSure Technologies

Based in Bethlehem, Pennsylvania, OraSure Technologies develops, manufactures and markets point-of-care, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, diagnostic products, including immunoassays and other in vitro diagnostic tests, and other medical devices. These products include tests for the detection of antibodies for the HIV virus, including OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test and the OraSure® HIV-1 Oral Specimen Collection Device, and oral fluid testing solutions for drugs of abuse testing, including Intercept® Oral Fluid Drug Testing System and Q.E.D.® Saliva Alcohol Test. These products are sold in the United States, as well as internationally, to various clinical laboratories, hospitals, clinics, community-based organizations, public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities. The Company also manufactures and sells several leading cryosurgical products. These include: Histofreezer®, a medical professional product for the cryosurgical removal of common, flat and plantar warts, and other benign skin lesions, sold to the professional or physician office market in the United States and many foreign countries. The Company also manufactures and sells an over-the-counter product for the cryosurgical removal of common and plantar warts, available in the United States, Canada, Mexico, certain European countries, Australia and New Zealand.
Company Growth (employees)
Type
Public
HQ
Bethlehem, US
Founded
1987
Size (employees)
325 (est)
OraSure Technologies was founded in 1987 and is headquartered in Bethlehem, US

OraSure Technologies Office Locations

OraSure Technologies has an office in Bethlehem
Bethlehem, US (HQ)
220 E 1st St
Bethlehem, US
1745 Eaton Ave
Bethlehem, US
150 Webster St

OraSure Technologies Data and Metrics

OraSure Technologies Financial Metrics

OraSure Technologies's revenue was reported to be $32.5 m in Q1, 2017
USD

Revenue (Q1, 2017)

32.5 m

Gross profit (Q1, 2017)

20.3 m

Gross profit margin (Q1, 2017), %

62%

Net income (Q1, 2017)

12.4 m

EBIT (Q1, 2017)

15.9 m

Market capitalization (25-Jul-2017)

1.1 b

Cash (31-Mar-2017)

120.9 m
OraSure Technologies's current market capitalization is $1.1 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

98.9 m106.5 m119.7 m128.2 m

Revenue growth, %

13%8%12%7%

Cost of goods sold

40.4 m39.8 m39.4 m40.2 m

Gross profit

58.6 m66.6 m80.3 m88 m

Gross profit Margin, %

59%63%67%69%

Sales and marketing expense

29.7 m

R&D expense

9.8 m

General and administrative expense

28.4 m

Operating expense total

70.8 m71.4 m72.2 m67.8 m

EBIT

(12.2 m)(4.8 m)8.1 m20.3 m

EBIT margin, %

(12%)(5%)7%16%

Pre tax profit

(12 m)(4.3 m)8.8 m20.3 m

Income tax expense

(772 k)343 k665 k603 k

Net Income

(11.2 m)(4.6 m)8.2 m19.7 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

26.4 m27.8 m27.1 m30.4 m29.9 m29.1 m31.4 m32.3 m32.5 m

Cost of goods sold

10.4 m9.1 m10.1 m9.7 m9.2 m8.8 m10.3 m9.6 m12.2 m

Gross profit

16 m18.7 m17 m20.7 m20.7 m20.3 m21.1 m22.7 m20.3 m

Gross profit Margin, %

61%67%63%68%69%70%67%70%62%

Sales and marketing expense

10.3 m9.2 m7.9 m8.9 m9.7 m8.7 m7.4 m6.4 m6.9 m

R&D expense

2.8 m3 m3.4 m3 m2.5 m2.4 m3 m3.2 m3 m

General and administrative expense

6 m5.6 m6 m6.1 m6.9 m6.5 m6.4 m6.9 m7.1 m

Operating expense total

19 m17.8 m17.3 m18 m19.1 m17.6 m16.7 m16.5 m16.9 m

EBIT

2.5 m882 k(291 k)2.7 m1.5 m2.7 m4.3 m6.1 m15.9 m

EBIT margin, %

9%3%(1%)9%5%9%14%19%49%

Pre tax profit

2.4 m1.2 m118 k2.6 m1.6 m2.5 m4 m6.6 m16.3 m

Income tax expense

(174 k)10 k5 k658 k147 k61 k173 k400 k3.9 m

Net Income

(3.1 m)(2 m)113 k2.1 m3.6 m2.4 m6.3 m12.5 m12.4 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

93.2 m92.9 m94.1 m108 m

Inventories

11.4 m15.8 m13.2 m11.8 m

Current Assets

119.6 m131.2 m136.7 m156.4 m

PP&E

17.9 m17.9 m20.1 m20 m

Goodwill

23.8 m21.7 m18.3 m18.8 m

Total Assets

184.2 m189.6 m189.3 m207.9 m

Accounts Payable

4.8 m7.1 m5.1 m4.6 m

Current Liabilities

19 m26.5 m25.2 m17.3 m

Additional Paid-in Capital

338.7 m344.9 m345.3 m350.5 m

Retained Earnings

(173.7 m)(178.3 m)(170.2 m)(150.5 m)

Total Equity

161.1 m158.7 m159.4 m185.9 m

Financial Leverage

1.1 x1.2 x1.2 x1.1 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

75.8 m93.9 m85.5 m83.4 m100.7 m94.6 m105.7 m111.7 m120.9 m

Inventories

13.2 m14.8 m15.6 m15.7 m15 m12.3 m11.4 m12.1 m12.7 m

Current Assets

115.8 m130 m123.2 m125.3 m141.8 m134.3 m146.4 m150.7 m180.5 m

PP&E

18.5 m18 m17.6 m17.9 m17.8 m20.2 m20.2 m20.1 m20.1 m

Goodwill

23.7 m22.6 m19.9 m20.2 m19 m19.4 m19.5 m19.2 m19 m

Total Assets

179.6 m190.5 m177.6 m180.1 m193.8 m188.5 m199.9 m203.6 m232.6 m

Accounts Payable

4.6 m4.5 m5 m4.7 m7 m5.3 m4 m4.4 m7.3 m

Current Liabilities

14.7 m25.3 m17.5 m15.6 m29.7 m20.3 m26.1 m22 m18.3 m

Additional Paid-in Capital

341.1 m342.9 m345.7 m347.1 m348.7 m343.5 m345.1 m347.3 m360.6 m

Retained Earnings

(176.8 m)(175.7 m)(178.2 m)(176.3 m)(174.8 m)(167.7 m)(163.9 m)(157.7 m)(138 m)

Total Equity

160.3 m160.9 m155.8 m159.9 m160 m163 m168.8 m176.5 m208.8 m

Financial Leverage

1.1 x1.2 x1.1 x1.1 x1.2 x1.2 x1.2 x1.2 x1.1 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(11.2 m)(4.6 m)8.2 m19.7 m

Depreciation and Amortization

6.6 m6.3 m5.7 m5.7 m

Accounts Receivable

4.3 m(3.4 m)(3.7 m)(576 k)

Inventories

1.3 m(4.4 m)2.3 m1.5 m

Accounts Payable

1.5 m2.2 m(2.6 m)46 k

Cash From Operating Activities

8.4 m7.5 m15.8 m22.8 m

Purchases of PP&E

(2.5 m)(3 m)(3.7 m)(4.4 m)

Cash From Investing Activities

(2.5 m)(8 m)(6.7 m)(8.1 m)

Cash From Financing Activities

(420 k)476 k(5.7 m)(1.2 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(3.1 m)(2 m)113 k2.1 m3.6 m2.4 m6.3 m12.5 m12.4 m

Depreciation and Amortization

3.1 m4.7 m1.4 m2.8 m4.3 m1.4 m2.8 m4.2 m1.4 m

Accounts Receivable

(1.2 m)(2.1 m)(552 k)(524 k)(1.6 m)2.5 m893 k3.8 m(4.1 m)

Inventories

(1.8 m)(3.4 m)57 k35 k633 k990 k1.9 m1.2 m(893 k)

Accounts Payable

(179 k)(284 k)(2.1 m)(2.5 m)(72 k)758 k(782 k)(125 k)2.6 m

Cash From Operating Activities

(10.4 m)8.4 m(6.6 m)(3.4 m)15.1 m4.7 m16.7 m23.4 m12.6 m

Purchases of PP&E

(2 m)(2.4 m)(437 k)(1.1 m)(1.9 m)(1.6 m)(2.7 m)(3.5 m)(878 k)

Cash From Investing Activities

(6.4 m)(7.3 m)602 k(4.1 m)(4.8 m)(1.6 m)(2.7 m)(3.5 m)(8.4 m)

Cash From Financing Activities

(437 k)(93 k)(651 k)(759 k)(759 k)(3.2 m)(3.1 m)(2.8 m)8.6 m

Income Taxes Paid

42 k42 k81 k81 k230 k84 k556 k812 k1.9 m
USDY, 2017

Revenue/Employee

100.1 k

Financial Leverage

1.1 x

OraSure Technologies Operating Metrics

OraSure Technologies's Facilities was reported to be 2 in FY, 2016
FY, 2016

Patents (US)

29

Facilities

2

    OraSure Technologies Market Value History

    OraSure Technologies Revenue Breakdown

    OraSure Technologies Company Life and Culture

    You may also be interested in